What is AOTI, Inc.'s (AOTI.L) StockRank?

MoatMap's StockRank for AOTI, Inc. (AOTI.L) is 73/100, with a Buy signal. This is a composite score combining Quality (55), Value (31), and Momentum (75) factor ranks across MoatMap's 20,000+ stock universe.

Does AOTI, Inc. have an economic moat?

AOTI, Inc. (AOTI.L) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is AOTI, Inc. a buy, hold, or sell?

MoatMap's current signal for AOTI, Inc. (AOTI.L) is Buy, based on a StockRank of 73/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is AOTI, Inc. in?

AOTI, Inc. (AOTI.L) operates in the Healthcare sector, specifically the Medical Devices industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

AOTI.L

BUYREMOVE

AOTI, Inc. · Healthcare · United States · $80M · Avg Vol: $9K/d

StockRank

P/E (TTM)

55.0x

ROE

14.3%

D/E

1.1x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

A micro-cap wound care technology company that lacks the scale, liquidity, and global distribution network required for a high-conviction position. It does not align with any of our active macro themes.

COMPANY DESCRIPTION

AOTI, Inc. is a medical technology company specializing in advanced wound care therapies, primarily through its patented Topical Wound Oxygen (TWO2) therapy. The company's home-use devices are clinically proven to reduce hospitalizations and amputations associated with diabetic foot ulcers. AOTI holds a strong competitive position protected by a robust IP portfolio and established reimbursement pathways in the United States and international markets.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	CAGR
Revenue	30.8M	45.0M	59.0M	78.3M	36.4%
EPS	0.03	-0.04	-0.10	-0.03	—
Shares	106.4M	106.4M	106.4M	106.4M	0.0%
Debt	0.4M	16.7M	16.6M	12.0M	221.3%
Equity	2.0M	1.0M	-7.9M	23.4M	125.4%
Op CF	2.6M	-0.3M	-2.3M	-7.9M	—
Inv CF	-1.2M	-4.2M	-1.8M	-2.6M	—
Fin CF	-0.9M	7.7M	-0.3M	22.0M	—

PRICE (1Y)-6.3%

SMA 50SMA 200

$0.79

RSI (14)

50.0

52W High

$1.27

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

3.2%51.4

ROE

14.3%81.3

GP/Assets

108.6%97.5

Op. Margin

10.3%66.7

FCF/Assets

-13.2%24.1

Piotroski

—28.7

Int. Cover

0.5x40.4

D/E Ratio

1.06x14.0

Current Ratio

3.11x54.7

Value

P/E (TTM)

55.0x18.0

EV/EBITDA

12.7x33.7

P/FCF

—N/A

P/B

5.3x22.6

P/S

1.2x81.0

Div Yield

—N/A

Momentum

52W High %

62%44.5

RS 6M

75%95.8

SMA 50/200

1.30x94.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+185%86.4

Q Growth

15%58.2

FUNDAMENTALS

Market Cap

$80M

P/E (Forward)

19.3x

Gross Margin

87.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AOTI.L are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
AOTI.L	AOTI, Inc.(you)	$80M	73	BUY
ECOR	electroCore, Inc.	$77M	67	BUY
INGN	Inogen, Inc.	$177M	64	HOLD
MASS	908 Devices Inc.	$338M	80	BUY
KIDS	OrthoPediatrics Corp.	$457M	69	BUY
RCEL	AVITA Medical, Inc.	$135M	41	HOLD
APYX	Apyx Medical Corporation	$174M	45	HOLD
DCTH	Delcath Systems, Inc.	$378M	87	STRONG BUY
CERS	Cerus Corporation	$585M	67	BUY
ELMD	Electromed, Inc.	$325M	96	STRONG BUY

Peer medians: ROE -22.7% · P/E 25.1x · Gross margin 44.3%

AOTI, Inc. (AOTI.L) — Stock Score Summary

AOTI, Inc. (AOTI.L) has a MoatMap StockRank of 73/100 based on Quality (55/100), Value (31/100), and Momentum (75/100) factor scores. The current signal is BUY. A micro-cap wound care technology company that lacks the scale, liquidity, and global distribution network required for a high-conviction position. It does not align with any of our active macro themes.

Key Financial Metrics

Price	$0.79
Market Cap	$80M
P/E (TTM)	55.00
P/E (Forward)	19.30
Price/Book	5.31
Return on Equity	14.3%
Return on Invested Capital	3.2%
Debt/Equity	106.27
Gross Margin	87.5%
Operating Margin	10.3%
Revenue Growth	8.3%
Free Cash Flow	$-9M

AOTI, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is AOTI, Inc.’s (AOTI.L) StockRank?: MoatMap’s StockRank for AOTI, Inc. (AOTI.L) is 73/100, with a Buy signal. It is a composite of Quality (55), Value (31), and Momentum (75) factor ranks across MoatMap’s 20,000+ stock universe.
Does AOTI, Inc. have an economic moat?: AOTI, Inc. (AOTI.L) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is AOTI, Inc. a buy, hold, or sell?: MoatMap’s current signal for AOTI, Inc. (AOTI.L) is Buy, based on a StockRank of 73/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is AOTI, Inc. in?: AOTI, Inc. (AOTI.L) operates in the Healthcare sector, specifically the Medical Devices industry (United States).